{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T04:18:09Z","timestamp":1748319489562,"version":"3.41.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["J Addict Med"],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>The COVID-19 pandemic prompted healthcare delivery changes, but the associated impacts on substance use disorder treatment outcomes among pregnant and parenting people are unknown. This study aims to (1) describe COVID-19\u2013driven clinical practice changes, (2) evaluate clinic-level visit attendance patterns, and (3) compare patient-level treatment engagement outcomes across 3 COVID-19 pandemic phases in an OBGYN-addiction treatment clinic.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>COVID-19 phases include pre\u2013COVID-19 (August 2019\u2013February 2020), early COVID-19 (March\u2013December 2020), and COVID-19 vaccine (January\u2013July 2021). OBGYN-addiction treatment clinical practice changes were summarized. Clinic-level attended medical provider visits were analyzed. Patient-level treatment engagement outcomes (buprenorphine continuation, visit attendance, and virtual visits) were assessed in a cohort of pregnant and parenting people enrolled in a clinic research registry. Mixed-level logistic regression models determined the relationship between the COVID-19 phases and the patient-level outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The study site made several COVID-19\u2013driven clinical practice changes, including implementing a hybrid virtual\/in-person system for medical visits. Clinic-level medical provider appointments increased between the first and second COVID-19 phases and remained high in the third phase. Among participants included in patient-level outcome analyses (N = 27), there were no differences in the early COVID-19 phase compared with the pre\u2013COVID-19 phase in buprenorphine continuation, any visits, or medical visits. There was a decrease in all patient-level outcomes in the COVID-19 vaccine phase compared with pre\u2013COVID-19 (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.05). Virtual visits increased between the first 2 phases and remained high during the third.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Within our OBGYN-addiction treatment clinic, implementation of tailored, patient-centered treatment strategies supported clinic- and patient-level treatment engagement throughout the pandemic.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/adm.0000000000001122","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T21:40:25Z","timestamp":1675374025000},"page":"e183-e191","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of COVID-19\u2013Driven Changes in an Integrated OBGYN-Addiction Treatment Clinic and Future Implications"],"prefix":"10.1097","volume":"17","author":[{"given":"Sumaya","family":"Smarony","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Beth","family":"Parlier-Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Shadowen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhushan","family":"Thakkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjorie O.","family":"Scheikl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caitlin E.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,12,21]]},"reference":[{"key":"bib2-20250526","first-page":"n1343","article-title":"Effect of the covid-19 pandemic in 2020 on life expectancy across populations in the USA and other high income countries: Simulations of provisional mortality data","volume":"373","year":"2021","journal-title":"BMJ"},{"issue":"32","key":"bib3-20250526","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.15585\/mmwr.mm6932a1","article-title":"Mental health, substance use, and suicidal ideation during the COVID-19 pandemic\u2014United States, June 24-30, 2020","volume":"69","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"bib4-20250526","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41380-020-00880-7","article-title":"COVID-19 risk and outcomes in patients with substance use disorders: Analyses from electronic health records in the United States","volume":"26","year":"2021","journal-title":"Mol Psychiatry"},{"issue":"5","key":"bib9-20250526","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.dsx.2020.05.035","article-title":"Psychosocial impact of COVID-19","volume":"14","year":"2020","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"issue":"12","key":"bib10-20250526","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1001\/jamapsychiatry.2020.1698","article-title":"Telehealth for substance-using populations in the age of coronavirus disease 2019: Recommendations to enhance adoption","volume":"77","year":"2020","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"bib11-20250526","doi-asserted-by":"crossref","first-page":"286","DOI":"10.5498\/wjp.v5.i3.286","article-title":"Usefulness of telepsychiatry: A critical evaluation of videoconferencing-based approaches","volume":"5","year":"2015","journal-title":"World J Psychiatry"},{"key":"bib12-20250526","first-page":"j1550","article-title":"Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies","volume":"357","year":"2017","journal-title":"BMJ"},{"key":"bib14-20250526","doi-asserted-by":"crossref","first-page":"107679","DOI":"10.1016\/j.drugalcdep.2019.107679","article-title":"Unmet substance use disorder treatment need among reproductive age women","volume":"206","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"bib15-20250526","doi-asserted-by":"crossref","first-page":"108180","DOI":"10.1016\/j.jsat.2020.108180","article-title":"COVID-19-related treatment service disruptions among people with single- and polysubstance use concerns","volume":"121","year":"2021","journal-title":"J Subst Abuse Treat"},{"issue":"2","key":"bib16-20250526","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/add.14825","article-title":"Maternal and infant characteristics associated with maternal opioid overdose in the year following delivery","volume":"115","year":"2020","journal-title":"Addiction"},{"issue":"2","key":"bib17-20250526","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/AOG.0000000000002734","article-title":"Fatal and nonfatal overdose among pregnant and postpartum women in Massachusetts","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"1, pt 2","key":"bib18-20250526","first-page":"462","article-title":"Nonfinancial barriers and access to care for U.S. adults","volume":"47","year":"2012","journal-title":"Health Serv Res"},{"issue":"1","key":"bib19-20250526","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13011-020-00284-4","article-title":"Barriers, facilitators, and disparities in retention for adolescents in treatment for substance use disorders: a qualitative study with treatment providers","volume":"15","year":"2020","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"bib20-20250526","doi-asserted-by":"crossref","first-page":"113348","DOI":"10.1016\/j.socscimed.2020.113348","article-title":"Vulnerability and resilience to pandemic-related stress among U.S. women pregnant at the start of the COVID-19 pandemic","volume":"266","year":"2020","journal-title":"Soc Sci Med"},{"issue":"3","key":"bib21-20250526","doi-asserted-by":"crossref","first-page":"e220093","DOI":"10.1001\/jamahealthforum.2022.0093","article-title":"Trends in engagement with opioid use disorder treatment among Medicaid beneficiaries during the COVID-19 pandemic","volume":"3","year":"2022","journal-title":"JAMA Health Forum"},{"issue":"6","key":"bib22-20250526","first-page":"448","article-title":"Adaptation of a system of treatment for substance use disorders during the COVID-19 pandemic","volume":"15","year":"2020","journal-title":"J Addict Med"},{"issue":"5","key":"bib23-20250526","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.ajog.2020.08.003","article-title":"Unintended consequences of the transition to telehealth for pregnancies complicated by opioid use disorder during the coronavirus disease 2019 pandemic","volume":"223","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"bib24-20250526","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.15585\/mmwr.mm695152e2","article-title":"The advisory committee on immunization practices' updated interim recommendation for allocation of COVID-19 vaccine\u2014United States, December 2020","volume":"69","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"bib25-20250526","doi-asserted-by":"crossref","first-page":"101834","DOI":"10.1016\/j.jcrimjus.2021.101834","article-title":"Examining the immediate effects of COVID-19 on residential and commercial burglaries in Michigan: An interrupted time-series analysis","volume":"76","year":"2021","journal-title":"Journal of Criminal Justice"},{"issue":"2","key":"bib26-20250526","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s10461-020-02976-1","article-title":"Potential influences of the COVID-19 pandemic on drug use and HIV care among people living with HIV and substance use disorders: Experience from a pilot mHealth intervention","volume":"25","year":"2021","journal-title":"AIDS Behav"},{"issue":"4","key":"bib27-20250526","doi-asserted-by":"crossref","first-page":"424.e1","DOI":"10.1016\/j.ajog.2021.04.210","article-title":"Methadone and buprenorphine discontinuation among postpartum women with opioid use disorder","volume":"225","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"bib29-20250526","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2006.05.012","article-title":"Substance abuse treatment entry, retention, and outcome in women: A review of the literature","volume":"86","year":"2007","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"bib30-20250526","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1186\/s12884-020-03109-1","article-title":"Multi-service prevention programs for pregnant and parenting women with substance use and multiple vulnerabilities: Program structure and clients' perspectives on wraparound programming","volume":"20","year":"2020","journal-title":"BMC Pregnancy Childbirth"},{"issue":"1","key":"bib31-20250526","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1097\/ADM.0000000000000826","article-title":"Pregnant patients using opioids: Treatment access barriers in the age of COVID-19","volume":"16","year":"2022","journal-title":"J Addict Med"},{"issue":"5","key":"bib32-20250526","doi-asserted-by":"crossref","first-page":"e0232086","DOI":"10.1371\/journal.pone.0232086","article-title":"Retention of patients in opioid substitution treatment: A systematic review","volume":"15","year":"2020","journal-title":"PLoS One"},{"issue":"4","key":"bib33-20250526","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/AOG.0000000000004539","article-title":"Home induction of buprenorphine for treatment of opioid use disorder in pregnancy","volume":"138","year":"2021","journal-title":"Obstet Gynecol"},{"issue":"6","key":"bib34-20250526","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1080\/09540261.2021.1908966","article-title":"Comprehensive and compassionate responses for opioid use disorder among pregnant and parenting women","volume":"33","year":"2021","journal-title":"Int Rev Psychiatry"},{"issue":"6","key":"bib35-20250526","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1080\/09540261.2021.1898349","article-title":"Addiction treatment in the postpartum period: An opportunity for evidence-based personalized medicine","volume":"33","year":"2021","journal-title":"Int Rev Psychiatry"},{"key":"bib36-20250526","article-title":"Caring for women with substance use disorders through pregnancy and postpartum during the COVID-19 pandemic: Lessons learned from psychology trainees in an integrated OBGYN\/substance use disorder outpatient treatment program","volume":"122","year":"2021","journal-title":"J Subst Abuse Treat"},{"issue":"2","key":"bib37-20250526","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1176\/appi.ajp.2019.19121284","article-title":"Personalizing the treatment of substance use disorders","volume":"177","year":"2020","journal-title":"Am J Psychiatry"},{"issue":"1","key":"bib38-20250526","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcjd.2020.11.013","article-title":"Reflections on virtual care for chronic conditions during the COVID-19 pandemic","volume":"45","year":"2021","journal-title":"Can J Diabetes"},{"key":"bib39-20250526","doi-asserted-by":"crossref","first-page":"120712","DOI":"10.1016\/j.techfore.2021.120712","article-title":"Opportunities and challenges for contactless healthcare services in the post-COVID-19 era","volume":"167","year":"2021","journal-title":"Technol Forecast Soc Change"},{"issue":"4","key":"bib40-20250526","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1176\/appi.ps.202100080","article-title":"Well-being of health care professionals treating opioid use disorder during the COVID-19 pandemic: Results from a national survey","volume":"73","year":"2022","journal-title":"Psychiatr Serv"}],"container-title":["Journal of Addiction Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ADM.0000000000001122","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T20:05:58Z","timestamp":1748289958000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/ADM.0000000000001122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,21]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/adm.0000000000001122","relation":{},"ISSN":["1932-0620"],"issn-type":[{"type":"print","value":"1932-0620"}],"subject":[],"published":{"date-parts":[[2022,12,21]]}}}